e-learning
resources
Milan 2017
Sunday, 10.09.2017
Current challenges in COPD evaluation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The value of FENO50 measurement in COPD – results from the TIE-study
A. Thornadtsson (Gävle, Sweden)
Source:
International Congress 2017 – Current challenges in COPD evaluation
Session:
Current challenges in COPD evaluation
Session type:
Poster Discussion
Number:
389
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Thornadtsson (Gävle, Sweden). The value of FENO50 measurement in COPD – results from the TIE-study. 389
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
The predictive value of FEV1 for COPD death in construction workers
Source: Eur Respir J 2001; 18: Suppl. 33, 275s
Year: 2001
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
The effect of adopting new GLI-2012 spirometric reference values on airflow limitation GOLD classification
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
The different results of the six minutes walking-test in COPD patients with or without significant improvement of inspiratory capacity after bronchodilator test
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004
Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD
Source: Eur Respir J 2004; 24: 332
Year: 2004
Spirometric data quality as assessed by repeatability in COPD exacerbations
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Spirometric values in a random population sample and their relation to ERS reference values and COPD criteria
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The contribution of lung hyperinflation to the reproducibility of arterial stiffness measurements in COPD: A comparison of techniques
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Changes in FEV
1
over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
Source: Breathe, 15 (4) 337; 10.1183/20734735.0252-2019
Year: 2019
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
FEV
6
: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004
Accuracy for DLco impairment through ventilatory efficiency indices in smokers without COPD.
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept